NCRI Newsletter | April 2020
Date published: Apr 30 2020
While NCRI is aware of the significant challenges the community is currently facing, we are continuing to bring the cancer research community together to support our mission. NCRI Groups have moved meetings to a virtual format, and are maintaining momentum in trial development while also discussing the impact of COVID-19 on current cancer research studies and identifying the opportunities and challenges that it brings.
NCRI’s Clinical and Translational Radiotherapy Research Group (CTRad) have announced a national initiative to study the impact of COVID-19 on radiotherapy services and patient outcomes. The Living with and Beyond Cancer (LWBC) Group have identified themes for potential LWBC research including changes in treatments, shielding, bereavement, isolation and changes in end-of-life practices.
The NCRI Consumer Forum has been meeting regularly online, sharing personal experiences of COVID-19. NCRI Consumers were also involved in a virtual workshop to understand their experiences when involved in projects that use health data, as part of a wider project with Health Data Research UK (HDR UK) the Health Data Research Hub for Cancer (DATA-CAN) and use MY data.
After careful consideration we have made the difficult decision to postpone the 2020 NCRI Cancer Conference, originally scheduled for 2-4 November in Belfast, UK. The next face-to-face Conference will take place in Manchester, as initially planned, from 7-9 November 2021. Please read the full statement on our website for more information and complete this survey to share your thoughts on virtual events.